Avishay Spitzer
Tel Aviv, TA, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Single-nucleus transcriptomics, pharmacokinetics, and pharmacodynamics of CDK4/6 and mTOR inhibition in a Phase 0/1 trial of recurrent high-grade glioma.
Journal: Neuro-oncology
Published: March 26, 2025
Oncogenic IDH1mut drives robust loss of histone acetylation and increases chromatin heterogeneity.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 10, 2025
A blueprint for local and distal invasion programs in glioblastoma.
Journal: Nature communications
Published: November 01, 2024
Acquired genetic and cell-state changes in IDH-mutant glioma progression.
Journal: Nature
Published: October 05, 2024
Lymphocyte to White Blood Cell Count Ratio an Independent Risk Factor for Heart Failure.
Journal: Life (Basel, Switzerland)
Published: August 29, 2024
Single nucleus transcriptomics, pharmacokinetics, and pharmacodynamics of combined CDK4/6 and mTOR inhibition in a phase 0/1 trial of recurrent high-grade glioma.
Journal: medRxiv : the preprint server for health sciences
Published: June 17, 2024
The multilayered transcriptional architecture of glioblastoma ecosystems.
Journal: Nature genetics
Published: April 05, 2024
Relationship among sleep, work features, and SARS-cov-2 vaccine antibody response in hospital workers.
Journal: Sleep medicine
Published: February 18, 2024
Mutant IDH inhibitors induce lineage differentiation in IDH-mutant oligodendroglioma.
Journal: Cancer cell
Published: February 02, 2023
Last Updated: 09/26/2026